Allopurinol
The active substance of A is allopurinol. Allopurinol belongs to a group of medicines called enzyme inhibitors. These substances are effective in controlling the rate of certain changes in the body.
A is used long-term to prevent gout and may be used in other conditions related to an excess of uric acid in the body, such as kidney stones and other kidney diseases, as well as when the patient is receiving treatment for cancer or has enzyme function disorders.
In case of doubts before taking A, consult your doctor.
Before starting to take A, discuss it with your doctor if:
Particular caution should be exercised when taking A:
The use of A in children is rarely indicated, except for certain cancers (especially leukemia) and certain enzyme disorders, such as Lesch-Nyhan syndrome.
It is particularly important to tell your doctor if you are taking any of the following medicines. Your doctor may need to reduce the dose of A and/or monitor you more closely due to the increased risk of side effects when A is taken with the following medicines:
If aluminum hydroxide is taken at the same time, allopurinol may have a weaker effect. You should maintain an interval of at least 3 hours between taking both medicines.
Blood disorders occur more frequently when allopurinol is taken with cytostatics (e.g., cyclophosphamide, doxorubicin, bleomycin, procarbazine, alkyl halides) than when these active substances are taken alone.
Therefore, you should regularly undergo blood morphology tests.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before taking this medicine. Allopurinol is excreted in the breast milk of nursing mothers. It is not recommended to take allopurinol during breastfeeding.
A tablets may cause drowsiness or coordination disorders. If such symptoms occur, do not drive or operate machines.
If you have been diagnosed with intolerance to some sugars, you should consult your doctor before taking the medicine.
This medicine should always be taken as directed by your doctor. If you have any doubts, consult your doctor.
Method of administration
A should be taken orally, once a day, after a meal, with a glass of water.
The amount of A that can be taken may vary greatly. Your doctor will decide on the dose of A that is suitable for you.
Recommended dose
Usual doses range from 100 to 300 mg per day. The dose may be increased to 900 mg per day, depending on the severity of the disease.
Doses greater than 300 mg should be taken in divided doses, not exceeding 300 mg at a time. Your doctor will usually start treatment with a low dose of allopurinol (e.g., 100 mg per day) to reduce the risk of side effects. If necessary, the dose will be increased.
In elderly patients or patients with liver or kidney function disorders, your doctor will usually use a lower dose or recommend longer intervals between doses.
In the case of patients undergoing dialysis two or three times a week, your doctor may recommend taking the medicine in a dose of 300 or 400 mg per day, which is taken immediately after dialysis.
Usual doses range from 100 to 400 mg per day.
If you have taken a higher dose of A than recommended, consult your doctor or go to the hospital immediately. Show your doctor the package with the tablets.
Symptoms of overdose may include nausea, vomiting, diarrhea, and dizziness.
If you miss a dose, take the next scheduled dose as soon as possible.
If it is almost time for the next dose, skip the missed dose.
Do not take a double dose to make up for the missed dose.
Do not stop treatment without consulting your doctor.
If you have any further doubts about taking this medicine, consult your doctor, nurse, or pharmacist.
Like all medicines, A can cause side effects, although not everybody gets them.
Uncommon(may affect less than 1 in 100 people):
You should immediatelyconsult your doctor if you experience any of the following symptoms:
Rare(may affect less than 1 in 1,000 people):
Very rare(may affect less than 1 in 10,000 people):
Frequency not known(cannot be estimated from the available data):
THE ABOVE SYMPTOMS MAY INDICATE THAT YOU ARE ALLERGIC TO ALLUPOL. In such cases, DO NOTcontinue treatment, unless your doctor advises otherwise.
Common(may affect less than 1 in 10 people):
Uncommon(may affect less than 1 in 100 people):
Rare(may affect less than 1 in 1,000 people):
Very rare(may affect less than 1 in 10,000 people):
Frequency not known(cannot be estimated from the available data):
If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: 22 49-21-301
Fax: 22 49-21-309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton.
The expiry date refers to the last day of the month stated.
Do not store above 25°C
No special precautions for storage.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
White, round, flat tablets with a dividing line.
The dividing line on the tablet is only to facilitate breaking the tablet to make it easier to swallow and not to divide it into equal doses.
The pack contains 50 tablets and an information leaflet.
White, round, 12 mm in diameter, convex tablets with a dividing line embossed on one side and "300" embossed on the other side.
The tablet can be divided into equal doses.
The medicine is packaged in aluminum/PVC blisters placed in a cardboard box.
The box contains 30 tablets and a patient information leaflet.
GEDEON RICHTER POLSKA Sp. z o.o.
ul. Ks. J. Poniatowskiego 5
05-825 Grodzisk Mazowiecki
phone: +48 (22) 755 50 81
Poland
To obtain more detailed information, contact:
GEDEON RICHTER POLSKA Sp. z o.o.
ul. Ks. J. Poniatowskiego 5
05-825 Grodzisk Mazowiecki
phone: +48 (22) 755 96 48
lekalert@grodzisk.rgnet.org
((marketing authorization holder's logo))
((pharmacode))
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.